|
|
Volumn 22, Issue 10, 1996, Pages 673-682
|
|
Mechanism of action and impact of a cystitis clinical practice guideline on outcomes and costs of care in an HMO.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
ADULT;
ARTICLE;
CASE CONTROL STUDY;
CYSTITIS;
DRUG UTILIZATION;
ECONOMICS;
FEMALE;
HEALTH CARE COST;
HEALTH CARE PLANNING;
HEALTH MAINTENANCE ORGANIZATION;
HUMAN;
MEDICAL AUDIT;
METHODOLOGY;
MIDDLE AGED;
NURSING;
ORGANIZATION AND MANAGEMENT;
PATIENT CARE;
PATIENT CARE PLANNING;
PRACTICE GUIDELINE;
STANDARD;
TOTAL QUALITY MANAGEMENT;
TREATMENT OUTCOME;
UNITED STATES;
URINALYSIS;
UTILIZATION REVIEW;
ADULT;
ANTI-BACTERIAL AGENTS;
CASE-CONTROL STUDIES;
CYSTITIS;
DRUG UTILIZATION;
FEMALE;
HEALTH CARE COSTS;
HEALTH MAINTENANCE ORGANIZATIONS;
HEALTH PLAN IMPLEMENTATION;
HUMANS;
MEDICAL AUDIT;
MIDDLE AGED;
MIDWESTERN UNITED STATES;
PATIENT CARE PLANNING;
PATIENT CARE TEAM;
PRACTICE GUIDELINES;
TOTAL QUALITY MANAGEMENT;
TREATMENT OUTCOME;
URINALYSIS;
|
|
EID: 0030253882
PISSN: 10703241
EISSN: None
Source Type: Journal
DOI: 10.1016/S1070-3241(16)30274-7 Document Type: Article |
|
Times cited : (50)
|
|
References (0)
|
